Pricing Log in Create free account
Saturday 17 October 2026 Export GEHC’s income statement to Excel — free account

GE HealthCare Technologies Inc.

GEHC Healthcare Medical Devices

GE HealthCare Technologies Inc.’s revenue for fiscal 2025 (year ended December 2025) was $20.6 billion, up 4.84% from fiscal 2024. In the quarter to June 2026, revenue grew 5.75%, EPS grew 17.0%, free cash flow grew 750.0% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; dividend growth for three consecutive years, revenue growth for five; insiders bought in the last twelve months.

69.57 0.78 −1.11%
Market cap
$31.8B
P/E
16.0×
Fwd P/E
14.4×
Dividend yield
0.26%
F-score
4/9
Altman Z
1.96
Beneish M
−2.33
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

GE HealthCare Technologies Inc. (GEHC) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, GE HealthCare Technologies Inc. (GEHC) trades at a EV/EBITDA of 12.3×. Over the past ten years it has ranged from 0.0× (December 2022) to 16.8× (March 2024); the current reading is higher than 23% of that period. That is above the Medical Devices industry median of 11.5× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 13.3× (1.10%)
FY2024 13.5× (4.93%)
FY2023 14.2× 38.90%
FY2022 10.2× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 11.5× (10.61%)
Mar 2026 12.9× (3.59%)
Dec 2025 13.3× 4.97%
Sep 2025 12.7× 1.31%
14 more quarters

Against its own ten years

Low 0.0× High 16.8×
Ten-year median 13.2×
Current reading's percentile 23

EV/EBITDA against peers

Company EV/EBITDA
SNN Smith & Nephew SNATS, Inc. compare 6.0×
PHG Koninklijke Philips N.V. compare 8.8×
ZBH Zimmer Biomet Holdings, Inc. compare 11.0×
GEHC GE HealthCare Technologies Inc. 12.3×
BSX Boston Scientific Corporation compare 13.9×
STE STERIS plc compare 14.2×
DXCM DexCom, Inc. compare 23.5×
EW Edwards Lifesciences Corporation compare 29.0×
PEN Penumbra, Inc. compare 58.6×
Medical Devices industry median 11.5×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on GEHC